ATAI
Price
$1.21
Change
-$0.09 (-6.92%)
Updated
Apr 10 closing price
Capitalization
257.8M
39 days until earnings call
LCTX
Price
$0.41
Change
-$0.00 (-0.00%)
Updated
Apr 10 closing price
Capitalization
94.68M
27 days until earnings call
Ad is loading...

ATAI vs LCTX

Header iconATAI vs LCTX Comparison
Open Charts ATAI vs LCTXBanner chart's image
ATAI Life Sciences
Price$1.21
Change-$0.09 (-6.92%)
Volume$2.23M
Capitalization257.8M
Lineage Cell Therapeutics
Price$0.41
Change-$0.00 (-0.00%)
Volume$755.13K
Capitalization94.68M
ATAI vs LCTX Comparison Chart
Loading...
ATAI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LCTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATAI vs. LCTX commentary
Apr 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATAI is a Hold and LCTX is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 11, 2025
Stock price -- (ATAI: $1.21 vs. LCTX: $0.41)
Brand notoriety: ATAI and LCTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATAI: 70% vs. LCTX: 52%
Market capitalization -- ATAI: $257.8M vs. LCTX: $94.68M
ATAI [@Biotechnology] is valued at $257.8M. LCTX’s [@Biotechnology] market capitalization is $94.68M. The market cap for tickers in the [@Biotechnology] industry ranges from $263.69B to $0. The average market capitalization across the [@Biotechnology] industry is $1.94B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATAI’s FA Score shows that 1 FA rating(s) are green whileLCTX’s FA Score has 0 green FA rating(s).

  • ATAI’s FA Score: 1 green, 4 red.
  • LCTX’s FA Score: 0 green, 5 red.
According to our system of comparison, LCTX is a better buy in the long-term than ATAI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATAI’s TA Score shows that 3 TA indicator(s) are bullish while LCTX’s TA Score has 4 bullish TA indicator(s).

  • ATAI’s TA Score: 3 bullish, 5 bearish.
  • LCTX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, LCTX is a better buy in the short-term than ATAI.

Price Growth

ATAI (@Biotechnology) experienced а -7.98% price change this week, while LCTX (@Biotechnology) price change was -1.75% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.43%. For the same industry, the average monthly price growth was -15.00%, and the average quarterly price growth was -16.98%.

Reported Earning Dates

ATAI is expected to report earnings on Aug 18, 2025.

LCTX is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+2.43% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ATAI($258M) has a higher market cap than LCTX($94.7M). ATAI YTD gains are higher at: -9.023 vs. LCTX (-18.408). LCTX has higher annual earnings (EBITDA): -20.87M vs. ATAI (-124.33M). ATAI has more cash in the bank: 85.9M vs. LCTX (47.8M). LCTX has less debt than ATAI: LCTX (2.51M) vs ATAI (23.8M). LCTX has higher revenues than ATAI: LCTX (9.5M) vs ATAI (331K).
ATAILCTXATAI / LCTX
Capitalization258M94.7M272%
EBITDA-124.33M-20.87M596%
Gain YTD-9.023-18.40849%
P/E RatioN/AN/A-
Revenue331K9.5M3%
Total Cash85.9M47.8M180%
Total Debt23.8M2.51M947%
FUNDAMENTALS RATINGS
ATAI vs LCTX: Fundamental Ratings
ATAI
LCTX
OUTLOOK RATING
1..100
6567
VALUATION
overvalued / fair valued / undervalued
1..100
80
Overvalued
38
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9593
PRICE GROWTH RATING
1..100
6291
P/E GROWTH RATING
1..100
1247
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

LCTX's Valuation (38) in the null industry is somewhat better than the same rating for ATAI (80) in the Miscellaneous Commercial Services industry. This means that LCTX’s stock grew somewhat faster than ATAI’s over the last 12 months.

LCTX's Profit vs Risk Rating (100) in the null industry is in the same range as ATAI (100) in the Miscellaneous Commercial Services industry. This means that LCTX’s stock grew similarly to ATAI’s over the last 12 months.

LCTX's SMR Rating (93) in the null industry is in the same range as ATAI (95) in the Miscellaneous Commercial Services industry. This means that LCTX’s stock grew similarly to ATAI’s over the last 12 months.

ATAI's Price Growth Rating (62) in the Miscellaneous Commercial Services industry is in the same range as LCTX (91) in the null industry. This means that ATAI’s stock grew similarly to LCTX’s over the last 12 months.

ATAI's P/E Growth Rating (12) in the Miscellaneous Commercial Services industry is somewhat better than the same rating for LCTX (47) in the null industry. This means that ATAI’s stock grew somewhat faster than LCTX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ATAILCTX
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
76%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 1 day ago
88%
Momentum
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
85%
MACD
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
83%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
83%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
84%
Advances
ODDS (%)
Bullish Trend 19 days ago
80%
Bullish Trend 19 days ago
77%
Declines
ODDS (%)
Bearish Trend 4 days ago
85%
Bearish Trend 4 days ago
82%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
85%
View a ticker or compare two or three
Ad is loading...
ATAI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LCTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SHPAX18.76N/A
N/A
Saratoga Health & Biotechnology A
MUSBX30.84N/A
N/A
MFS Blended Research Core Equity B
OEGYX28.71N/A
N/A
Invesco Discovery Mid Cap Growth Y
GLOSX18.19N/A
N/A
Victory Pioneer Global Equity A
NWAVX14.14N/A
N/A
Nationwide GQG US Quality Eq R6

ATAI and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATAI has been loosely correlated with MNMD. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ATAI jumps, then MNMD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATAI
1D Price
Change %
ATAI100%
-6.92%
MNMD - ATAI
48%
Loosely correlated
-9.51%
CRSP - ATAI
47%
Loosely correlated
-1.81%
CYBN - ATAI
46%
Loosely correlated
+5.90%
COUR - ATAI
45%
Loosely correlated
-5.16%
VCYT - ATAI
45%
Loosely correlated
-7.27%
More